CV Lattes
ORCID
Abstract
The present project aims at the synthesis of (Z)-5-(4- (2-(methyl (pyridin-2-yl) amino) ethoxy) benzylidene) thiazolidine-2,4-dione, an intermediate of the drug Rosiglitazone, which is one of the anti-glycemic agents of the glitazone class, used to combat type 2 diabetes mellitus, and which works as an insulin sensitizer in humans. The synthesis of this intermediate will be carried out th…